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Development of Pulmonary Arteriovenous
Communications within Pulmonary Metastases
After Chemotherapy
John F. Bruzzi, FFRRCSI,* Mylene T. Truong, MD,* Gregory W. Gladish, MD,*
Michael J. Wallace, MD,† Cesar A. Moran, MD,‡ and Reginald F. Munden, MD*
The development of acquired pulmonary arteriovenous communica-
tions within pulmonary metastases from an extrathoracic malig-
nancy is a rare phenomenon, but it has potentially serious clinical
consequences for the patient. We describe two such patients, both of
whom developed intrametastatic pulmonary arteriovenous commu-
nications after chemotherapy of the pulmonary metastases, and one
of whom required coil embolization for control of symptoms related
to the right-to-left shunt. In both cases, computed tomographic
angiography was useful for the detection and pre-therapeutic eval-
uation of the arteriovenous malformations.
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Pulmonary arteriovenous malformations (PAVMs) arecharacterized by a direct communication between pulmo-
nary arteries and veins without an intervening capillary com-
ponent, resulting in an extracardiac right-to-left shunt.1 Most
cases are congenital, often seen in the context of hereditary
hemorrhagic telangiectasia,2 but in very rare cases, they may
develop within pulmonary metastases from an extrathoracic
malignancy after systemic chemotherapy.3–5 The detection of
PAVMs is important because the arteriovenous shunt can
cause symptoms such as dyspnea, hemoptysis, and paradox-
ical emboli that may be prevented or alleviated by appropriate
intervention.6,7 Computed tomographic (CT) imaging has been
shown to be useful for the diagnosis of PAVMs and can provide
important anatomical information before endovascular emboli-
zation or surgery.8 We describe the cases of two patients in
whom PAVMs developed within pulmonary metastases from an
extrathoracic malignancy after chemotherapy.
CASE 1
A 73-year-old woman who underwent radical nephrec-
tomy 12 years ago for renal cell carcinoma at our institution
presented with a 3-month history of progressive shortness of
breath, which was not alleviated by supplemental oxygen via
a nasal cannula. She also reported several episodes of minor
hemoptysis approximately 12 months earlier. She had no
cardiac history to account for her dyspnea.
The patient was known to have multiple pulmonary
metastases (confirmed histologically via thoracotomy and
wedge resection) that had developed 2 years after her ne-
phrectomy. She underwent multiple courses of chemotherapy
comprising 5-fluorouracil, -interferon, gemcitabine, and
capecitabine, which were initially effective and resulted in a
marked decrease in the size of the metastases. After initial
therapy, however, the metastases demonstrated slow but pro-
gressive enlargement. At the time of the patient’s current
presentation, she was receiving maintenance low-dose -in-
terferon therapy in combination with floxuridine.
Physical examination was unremarkable, apart from a
mild tachycardia and a low arterial oxygen saturation of 91%
despite 4 L of supplemental nasal oxygen. Laboratory exam-
ination revealed increased hemoglobin (16.6 g/dL), hemato-
crit (49.9), and increased erythropoietin (83.4 mIU/mL).
A CT scan performed without IV contrast (because of
chronic renal insufficiency) demonstrated numerous bilateral
pulmonary nodules and masses consistent with the known
pulmonary metastases. A contrast-enhanced CT pulmonary
angiogram was subsequently requested to exclude chronic
thromboembolic disease; it demonstrated marked contrast
enhancement within the pulmonary nodules, many of which
were closely related to pulmonary vessels (Figure 1A); there
was no evidence of pulmonary emboli.
Transthoracic echocardiography revealed hyperdy-
namic left ventricular function with an ejection fraction of
70%. A right heart catheterization was subsequently per-
formed to investigate the possibility of an intracardiac shunt;
we found decreased mixed venous O2 saturation of 70%, but
there was no evidence of intracardiac shunt, and right ven-
tricular pressures were normal (24/2 mmHg).
Based on these findings, arteriovenous shunting within
the pulmonary metastases was postulated. Pulmonary angiog-
raphy confirmed the presence of high-flow arteriovenous
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shunting within the largest pulmonary masses and nodules,
with lesser degrees of shunting within the smaller nodules.
Coil embolization was performed on the largest lesion in the
right infrahilar region, using 8- to 10-mm metal coils, result-
ing in an immediate increase of the patient’s arterial oxygen
saturation from the mid-80% level to the mid-90% range
(Figure 1B). After the procedure, the patient experienced a
marked symptomatic improvement and no longer required
supplemental oxygen.
CASE 2
A 47-year-old woman with metastatic uterine leiomy-
osarcoma was referred to our institution for a second opinion
regarding chemotherapy. At the time of her referral, the
patient’s primary pelvic tumor had been resected and she had
known pulmonary metastases, but she had not yet received
adjuvant chemotherapy. Initial staging CT scan of the chest
demonstrated numerous avidly-enhancing pulmonary nodules
with a predominantly perivascular distribution.
The patient subsequently received six cycles of gem-
citabine and docetaxel. At the time of re-evaluation, she was
symptomatically well and denied shortness of breath or he-
moptysis. Physical examination was unremarkable; there was
no evidence of cyanosis. Laboratory findings were also non-
contributory; hemoglobin and hematocrit levels were 9.9
g/dL and 29.8%, respectively, which were slightly low sec-
ondary to chemotherapeutic effect.
Restaging CT imaging of her thorax demonstrated a
partial response to therapy with a decrease in size of many of
the pulmonary metastases; however, many of the lesions
showed increased enhancement with evidence of internal
necrosis and central pooling of contrast material. Reformatted
images revealed aneurysm formation and arteriovenous com-
munications between pulmonary arteries and veins within
many of metastases (Figure 2A).
A thoracotomy and multiple right-sided pulmonary
wedge resections were performed of the pulmonary metasta-
ses on the right side. Histological examination revealed
extensive central necrosis within each of the metastases, with
vascular structures running through them (Figure 2B).
Repeat pulmonary wedge resections of all of the pul-
monary metastases were performed in staged procedures, and
the patient is currently free of detectable malignancy.
DISCUSSION
We describe two cases of PAVMs developing within
pulmonary metastases from an extrathoracic source. In both
cases, the metastases presented in a perivascular distribution
in the lungs representative of hematogenous dissemination;
after chemotherapy, arteriovenous communications devel-
oped within the metastases. For one of these patients, the
communications were hemodynamically important enough to
cause signs and symptoms of a right-to-left shunt and re-
quired endovascular coil embolization, which successfully
decreased the effects of the shunt, improving the degree of
arterial oxygenation to near-normal levels. For the other
patient, the communications were controlled by wedge resec-
tion of the metastases.
FIGURE 1. A 73-year-old woman with metastatic renal cell car-
cinoma. (A) Coronal oblique reformatted image from a CT scan
performed with IV contrast demonstrates an enhancing pulmo-
nary metastasis in the right infrahilar region, with an arterial
blood supply derived from the right interlobar pulmonary ar-
tery (arrow) and venous drainage into the right inferior pulmo-
nary vein (arrowhead). (B) Conventional pulmonary angiogra-
phy confirms the existence of a pulmonary arteriovenous shunt
within the metastasis, demonstrating early venous return to the
left atrium via the right inferior pulmonary vein (arrowhead).
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PAVMs arising within pulmonary metastases are a rare
phenomenon; there have been only a handful of reports of
such cases in the literature, predominantly involving patients
with metastatic choriocarcinoma.3–5 Gestational choriocarci-
noma is known to be a highly malignant neoplasm associated
with arteriovenous shunts in the uterus, often with persistence
of the shunts after chemotherapy. Pulmonary metastases from
these tumors resemble the primary neoplasm both on gross
specimens and at histology. On angiographic studies, chorio-
carcinoma metastases have been shown to be highly vascular
tumors, and they may be associated with pulmonary arterio-
venous shunting.3 The exact pathophysiology underlying the
development of pulmonary arteriovenous communications in
these cases is not fully understood. One mechanism postulated
by Casson et al. involves the formation of local arteriovenous
shunts within or adjacent to choriocarcinoma metastases, with
persistence of these communications after treatment of the tumor
metastases with chemotherapy.4 Such a phenomenon would
explain the development of multiple arteriovenous malforma-
tions in our first patient with metastatic renal cell carcinoma.
However, a different pathophysiological mechanism is
suggested in our second patient. In this patient with uterine
leiomyosarcoma and multiple pulmonary metastases, rapid
central necrosis developed within the metastases after che-
motherapy, as evidenced on serial CT imaging. On histolog-
ical examination of the resected metastases, it was apparent
that the communications between the pulmonary arteries and
veins were the result of tissue breakdown between these vessels
rather than to the formation of endothelialized arteriovenous
shunts. Although the patient was not symptomatic from these
communications, it is possible that there was a risk of paradox-
ical emboli, and in this context, interruption of these communi-
cations by surgery or embolotherapy would seem prudent.
Both of our cases were unusual in that they involved
pulmonary metastases from malignancies other than chorio-
carcinoma (renal cell carcinoma and uterine leiomyosarcoma,
respectively), from which the development of PAVMs has
not previously been described, to our knowledge. Evaluation
of these arteriovenous communications by CT angiography
was useful in both cases for accurately depicting the existence
of a shunt and for identifying the feeding arterial vessels.
CONCLUSION
The development of pulmonary arteriovenous commu-
nications within pulmonary metastases from an extrathoracic
malignancy is a rare occurrence but may cause symptoms
such as hypoxemia unalleviated by supplemental oxygen,
hemoptysis and a risk of paradoxical emboli. Thoracic CT
angiography can detect their presence and accurately depict
the anatomical abnormality before intervention.
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